Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Neurologia (Barcelona, Spain)|April 10, 2002
[Discrepancy between imaging and neurophysiology in deep brain stimulation of medial pallidum and subthalamic nucleus in Parkinson's disease]J Guridi, M C Rodríguez-Oroz, E Ramos, et al.Neurologia (Barcelona, Spain)|June 23, 1999
[Pathophysiological bases, clinical results and indications for surgical treatment in Parkinson disease]J A Obeso, G Linazasoro, A Gorospe, et al.Neurologia (Barcelona, Spain)|April 1, 1999
[Pallidotomy in the treatment of complicated Parkinson's disease: clinical results at two years and analysis of prognostic factors]G Linazasoro, A Gorospe, M C Rodríguez, et al.Clinical Neuropharmacology|October 12, 1999
Modification of dopamine D2 receptor activity by pergolide in Parkinson's disease: an in vivo study by PETG Linazasoro, J A Obeso, J C Gómez, et al.Revista De Neurologia|July 25, 2000
[Surgery of the subthalamic nucleus in Parkinson's disease]G Linazasoro, J Guridi, M C Rodríguez, et al.Neurology|February 24, 2001
Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's diseaseM C Rodriguez-Oroz, A Gorospe, J Guridi, et al.Revista De Neurologia|January 11, 2002
[Dopamine agonists situation in Parkinson disease]M Barbanoj, V M Campos Arillo, S Giménez-Roldán, et al.Neurologia (Barcelona, Spain)|February 21, 1998
[Stereotactic surgery in Parkinson's disease]G Linazasoro, J Guridi, L Vela, et al.Revista De Neurologia|June 10, 2020
Optimized clinical management of Parkinson's disease with opicapone. Recommendations from Spanish expertsG Linazasoro-Cristóbal, L J López Del Val, P García Ruiz-Espiga, et al.Neurologia (Barcelona, Spain)|July 5, 2011
Dopaminergic agonists in Parkinson's diseaseA Alonso Cánovas, R Luquin Piudo, P García Ruiz-Espiga, et al.Pageof 6